Advancements in cancer treatment have opened new doors for patients, providing more effective and tailored options. While traditional methods like surgery, chemotherapy, and radiation continue to play a crucial role, newer approaches are gaining ground. Targeted therapies focus on disrupting the specific molecular pathways that drive cancer growth, while immunotherapies harness the body’s immune system to better target cancer cells. Additionally, personalized medicine is revolutionizing treatment by customizing therapies based on the patient’s genetic makeup. Together, these innovations are transforming cancer care, offering greater hope for improved survival rates and quality of life.
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom